Literature DB >> 24589027

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

C A Kauffman1, A G Freifeld, D R Andes, J W Baddley, L Herwaldt, R C Walker, B D Alexander, E J Anaissie, K Benedict, J I Ito, K M Knapp, G M Lyon, K A Marr, V A Morrison, B J Park, T F Patterson, M G Schuster, T M Chiller, P G Pappas.   

Abstract

BACKGROUND: Invasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on the epidemiology of endemic fungal infections in these populations.
METHODS: Fifteen institutions belonging to the Transplant-Associated Infection Surveillance Network prospectively enrolled SOT and HCT recipients with histoplasmosis, blastomycosis, or coccidioidomycosis occurring between March 2001 and March 2006.
RESULTS: A total of 70 patients (64 SOT recipients and 6 HCT recipients) had infection with an endemic mycosis, including 52 with histoplasmosis, 9 with blastomycosis, and 9 with coccidioidomycosis. The 12-month cumulative incidence rate among SOT recipients for histoplasmosis was 0.102%. Occurrence of infection was bimodal; 28 (40%) infections occurred in the first 6 months post transplantation, and 24 (34%) occurred between 2 and 11 years post transplantation. Three patients were documented to have acquired infection from the donor organ. Seven SOT recipients with histoplasmosis and 3 with coccidioidomycosis died (16%); no HCT recipient died.
CONCLUSIONS: This 5-year multicenter prospective surveillance study found that endemic mycoses occur uncommonly in SOT and HCT recipients, and that the period at risk extends for years after transplantation.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blastomycosis; coccidioidomycosis; hematopoietic cell transplant; histoplasmosis; solid organ transplant

Mesh:

Substances:

Year:  2014        PMID: 24589027      PMCID: PMC5664161          DOI: 10.1111/tid.12186

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  23 in total

1.  Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center.

Authors:  A G Freifeld; P C Iwen; B L Lesiak; R K Gilroy; R B Stevens; A C Kalil
Journal:  Transpl Infect Dis       Date:  2005 Sep-Dec       Impact factor: 2.228

Review 2.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 3.  Coccidioidomycosis in solid organ transplantation.

Authors:  J E Blair; J L Logan
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

4.  Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients.

Authors:  E Blodget; P Jan Geiseler; R A Larsen; M Stapfer; Y Qazi; L M Petrovic
Journal:  Transpl Infect Dis       Date:  2011-12-18       Impact factor: 2.228

5.  Donor-derived organ transplant transmission of coccidioidomycosis.

Authors:  K L Dierberg; K A Marr; A Subramanian; H Nace; N Desai; J E Locke; S Zhang; J Diaz; C Chamberlain; D Neofytos
Journal:  Transpl Infect Dis       Date:  2011-12-18       Impact factor: 2.228

6.  Donor-related coccidioidomycosis in organ transplant recipients.

Authors:  Patty W Wright; Demosthenes Pappagianis; Mark Wilson; Ana Louro; Stephen A Moser; Kenneth Komatsu; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2003-10-01       Impact factor: 9.079

7.  Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.

Authors:  J Cuellar-Rodriguez; R K Avery; M Lard; M Budev; S M Gordon; N K Shrestha; D van Duin; M Oethinger; S D Mawhorter
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

8.  Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

Authors:  Philip C Johnson; L Joseph Wheat; Gretchen A Cloud; Mitchell Goldman; Dan Lancaster; David M Bamberger; William G Powderly; Richard Hafner; Carol A Kauffman; William E Dismukes
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

9.  Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America.

Authors:  Stanley W Chapman; William E Dismukes; Laurie A Proia; Robert W Bradsher; Peter G Pappas; Michael G Threlkeld; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Blastomycosis in solid organ transplant recipients.

Authors:  G M Gauthier; N Safdar; B S Klein; D R Andes
Journal:  Transpl Infect Dis       Date:  2007-04-11       Impact factor: 2.228

View more
  36 in total

1.  Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Raman Venkataramanan; Ryan M Rivosecchi; Chenxiao Tang; Rachel V Marini; Ryan K Shields; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 2.  The neurology of solid organ transplantation.

Authors:  J David Avila; Saša Živković
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  [Mycoses after organ transplantations].

Authors:  D Theegarten
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

4.  Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States.

Authors:  Kaitlin Benedict; Karlyn D Beer; Brendan R Jackson
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

Review 5.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

Review 6.  Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.

Authors:  Alisha Y Young; Miguel M Leiva Juarez; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-05-31       Impact factor: 2.878

7.  Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Cornelius J Clancy; Ryan M Rivosecchi; Wenchen Zhao; Ryan K Shields; Rachel V Marini; Raman Venkataramanan; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 8.  Endemic Mycoses in Solid Organ Transplant Recipients.

Authors:  Jeremy S Nel; Luther A Bartelt; David van Duin; Anne M Lachiewicz
Journal:  Infect Dis Clin North Am       Date:  2018-09       Impact factor: 5.982

Review 9.  Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors:  Judith A Anesi; John W Baddley
Journal:  Infect Dis Clin North Am       Date:  2015-12-28       Impact factor: 5.982

10.  Disseminated blastomycosis in coalworkers' pneumoconiosis.

Authors:  Utsav Shrestha; Chetan Naik; Arthur Huen; Keely Marshall; Karunamurthy Arivarasan; John McDyer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.